NASDAQ: INVA
Innoviva Inc Stock Forecast, Predictions & Price Target

Analyst price target for INVA

Based on 1 analyst offering 12 month price targets for Innoviva Inc

Min Forecast
$55.00+196.98%
Avg Forecast
$55.00+196.98%
Max Forecast
$55.00+196.98%

Should I buy or sell INVA stock?

Based on 1 analyst offering ratings for Innoviva Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although INVA's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates INVA as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their INVA stock forecasts and price targets.

INVA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-03-07

1 of 1

Forecast return on equity

Is INVA forecast to generate an efficient return?

Company
14.06%
Industry
117.29%
Market
45.6%
INVA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is INVA forecast to generate an efficient return on assets?

Company
7.47%
Industry
89.77%
INVA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

INVA earnings per share forecast

What is INVA's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
$1.55+318.92%

INVA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
INVA$18.52$55.00+196.98%Buy
IOVA$3.56$17.71+397.58%Strong Buy
LQDA$13.51$29.33+117.12%Buy
SNDX$13.70$36.60+167.15%Strong Buy
ADPT$7.61$10.25+34.69%Strong Buy

Innoviva Stock Forecast FAQ

Is Innoviva Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: INVA) stock is to Buy INVA stock.

Out of 1 analyst, 0 (0%) are recommending INVA as a Strong Buy, 1 (100%) are recommending INVA as a Buy, 0 (0%) are recommending INVA as a Hold, 0 (0%) are recommending INVA as a Sell, and 0 (0%) are recommending INVA as a Strong Sell.

If you're new to stock investing, here's how to buy Innoviva stock.

What is INVA's earnings growth forecast for 2025-2025?

(NASDAQ: INVA) Innoviva's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.

Innoviva's earnings in 2025 is $23,392,000.

In 2025, INVA is forecast to generate $97,147,095 in earnings, with the lowest earnings forecast at $97,147,095 and the highest earnings forecast at $97,147,095.

What is INVA's forecast return on equity (ROE) for 2025-2025?

(NASDAQ: INVA) forecast ROE is 14.06%, which is considered weak.

What is INVA's Price Target?

According to 1 Wall Street analyst that have issued a 1 year INVA price target, the average INVA price target is $55.00, with the highest INVA stock price forecast at $55.00 and the lowest INVA stock price forecast at $55.00.

The Wall Street analyst predicted that Innoviva's share price could reach $55.00 by Mar 7, 2026. The average Innoviva stock price prediction forecasts a potential upside of 196.98% from the current INVA share price of $18.52.

What is INVA's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: INVA) Innoviva's current Earnings Per Share (EPS) is $0.37. In 2025, INVA's EPS is forecast to hit $1.55 (min: $1.55, max: $1.55).

What is INVA's forecast return on assets (ROA) for 2025-2025?

(NASDAQ: INVA) forecast ROA is 7.47%, which is lower than the forecast US Biotechnology industry average of 89.77%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.